WO2005087195A3 - Novel compositions for topical delivery - Google Patents

Novel compositions for topical delivery Download PDF

Info

Publication number
WO2005087195A3
WO2005087195A3 PCT/IN2005/000086 IN2005000086W WO2005087195A3 WO 2005087195 A3 WO2005087195 A3 WO 2005087195A3 IN 2005000086 W IN2005000086 W IN 2005000086W WO 2005087195 A3 WO2005087195 A3 WO 2005087195A3
Authority
WO
WIPO (PCT)
Prior art keywords
compositions
pharmaceutical composition
treatment
novel compositions
topical delivery
Prior art date
Application number
PCT/IN2005/000086
Other languages
French (fr)
Other versions
WO2005087195A2 (en
Inventor
Rajesh Jain
Kour Chand Jindal
Sukhjeet Singh
Vaibhav Sihorkar
Original Assignee
Panacea Biotec Ltd
Rajesh Jain
Kour Chand Jindal
Sukhjeet Singh
Vaibhav Sihorkar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotec Ltd, Rajesh Jain, Kour Chand Jindal, Sukhjeet Singh, Vaibhav Sihorkar filed Critical Panacea Biotec Ltd
Priority to BRPI0508933-6A priority Critical patent/BRPI0508933A/en
Priority to CA002559351A priority patent/CA2559351A1/en
Priority to AP2006003784A priority patent/AP2006003784A0/en
Priority to US10/593,136 priority patent/US20080050434A1/en
Priority to AU2005221427A priority patent/AU2005221427B2/en
Priority to EP05733456A priority patent/EP1734925A2/en
Priority to RSP-2006/0479A priority patent/RS20060479A/en
Priority to EA200601724A priority patent/EA011244B1/en
Publication of WO2005087195A2 publication Critical patent/WO2005087195A2/en
Publication of WO2005087195A3 publication Critical patent/WO2005087195A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Pharmaceutical composition for topical administration comprising of at least one active ingredient, its salts, esters, hydrates or derivatives; a gelator system consisting of a fiend of surfactants, a solvent system comprising at least one oily component; an aqueous phase; optionally containing one or more stabilizing agent; and other pharmaceutically acceptable excipients; and process for preparing such compositions are provided. Also provided is a method for the management/treatment of fungal, bacterial or microbial infections, inflammations, autoimmune conditions, or hormonal disorders which comprises administering a pharmaceutically effective amount of such pharmaceutical composition to a subject in need of such treatment. The compositions of the present invention are non-greasy and easily water washable, and provides an enhanced localization of hydrophobic and/or amphiphilic active ingredients on the skin.
PCT/IN2005/000086 2004-03-18 2005-03-17 Novel compositions for topical delivery WO2005087195A2 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
BRPI0508933-6A BRPI0508933A (en) 2004-03-18 2005-03-17 compositions for topical delivery
CA002559351A CA2559351A1 (en) 2004-03-18 2005-03-17 Novel compositions for topical delivery
AP2006003784A AP2006003784A0 (en) 2004-03-18 2005-03-17 Novel compositions for topical delivery
US10/593,136 US20080050434A1 (en) 2004-03-18 2005-03-17 Novel Composition for Topical Delivery
AU2005221427A AU2005221427B2 (en) 2004-03-18 2005-03-17 Novel compositions for topical delivery
EP05733456A EP1734925A2 (en) 2004-03-18 2005-03-17 Novel compositions for topical delivery
RSP-2006/0479A RS20060479A (en) 2004-03-18 2005-03-17 Novel compositions for topical delivery
EA200601724A EA011244B1 (en) 2004-03-18 2005-03-17 Novel compositions for topical delivery

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN501DE2004 2004-03-18
IN501/DEL/2004 2004-03-18

Publications (2)

Publication Number Publication Date
WO2005087195A2 WO2005087195A2 (en) 2005-09-22
WO2005087195A3 true WO2005087195A3 (en) 2006-08-03

Family

ID=34976285

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2005/000086 WO2005087195A2 (en) 2004-03-18 2005-03-17 Novel compositions for topical delivery

Country Status (10)

Country Link
US (1) US20080050434A1 (en)
EP (1) EP1734925A2 (en)
AP (1) AP2006003784A0 (en)
AU (1) AU2005221427B2 (en)
BR (1) BRPI0508933A (en)
CA (1) CA2559351A1 (en)
EA (1) EA011244B1 (en)
RS (1) RS20060479A (en)
WO (1) WO2005087195A2 (en)
ZA (1) ZA200608621B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8575189B2 (en) 2008-10-08 2013-11-05 Takata Seiyaku Co., Ltd. Tacrolimus preparation for external applications

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ297215B6 (en) * 2005-04-06 2006-10-11 Zentiva, A. S. Topical medicamentous form containing nimesulide
MXPA05010457A (en) * 2005-09-28 2007-03-27 Fernando Ahumada Ayala Preparation for the treatment of inflammatory skin diseases, containing tacrolimus.
EP2005825A4 (en) * 2006-04-07 2012-03-28 Riken Insecticidal ovicidal composition and method of insect killing and egg killing
US12083103B2 (en) 2007-05-30 2024-09-10 Veloxis Pharmaceuticals, Inc. Tacrolimus for improved treatment of transplant patients
LT2167033T (en) 2007-05-30 2017-08-10 Veloxis Pharmaceuticals A/S Once daily oral dosage form comprising tacrolimus
WO2008154368A2 (en) * 2007-06-08 2008-12-18 University Of Virginia Patent Foundation Topical poloxamer formulations for enhancing microvascular flow: compositions and uses thereof
WO2009010986A1 (en) * 2007-07-19 2009-01-22 Glenmark Pharmaceuticals Limited Topical cream compositions of sertaconazole nitrate
EP2317993A2 (en) * 2008-07-23 2011-05-11 Tdt, Ltd Methods of administering topical antifungal formulations for the treatment of fungal infections
WO2010109425A2 (en) * 2009-03-25 2010-09-30 Sulur Subramaniam Vanangamudi A medicinal steroids cream and a process to make it
WO2010109418A1 (en) * 2009-03-25 2010-09-30 Sulur Subramaniam Vanangamudi A medicinal antifungal cream and a process to make it
WO2010119387A2 (en) * 2009-04-13 2010-10-21 Sulur Subramaniam Vanangamudi A medicinal cream made using miconazole nitrate, fluticasone propionate, and chitosan, and a process to make the same
EP2419084A2 (en) * 2009-04-13 2012-02-22 Vanangamudi, Sulur Subramaniam A medicinal cream made using clotrimazole and chitosan and a process to make the same
WO2010119386A2 (en) * 2009-04-13 2010-10-21 Sulur Subramaniam Vanangamudi A medicinal cream made using clotrimazole, fluticasone propionate, and chitosan, and a process to make the same
EP2419098A2 (en) * 2009-04-13 2012-02-22 Vanangamudi, Sulur Subramaniam A medicinal cream made using miconazole nitrate and chitosan, and a process to make the same
WO2011027247A1 (en) * 2009-09-03 2011-03-10 Sulur Subramaniam Vanangamudi An antifungal cream comprising terbinafine hydrochloride
WO2011027246A1 (en) * 2009-09-03 2011-03-10 Sulur Subramaniam Vanangamudi A cream comprising miconazole nitrate and a biopolymer for the treatment of diaper rash
EP2488016A4 (en) * 2009-10-02 2013-09-25 Yissum Res Dev Co Sanitizing compositions
RS55118B1 (en) * 2010-02-17 2016-12-30 Veloxis Pharmaceuticals As Stabilized tacrolimus composition
US8530409B1 (en) * 2012-06-12 2013-09-10 Dipexium Pharmaceuticals LLC Stable pexiganan formulation
US11806427B2 (en) * 2014-09-17 2023-11-07 Alps South Europe, S.R.O. Topical composition containing antioxidants
WO2016077556A1 (en) * 2014-11-12 2016-05-19 Research Foundation Of The City University Of New York Environmentally friendly gelator using medium chain triglycerides and method of use
WO2016094617A1 (en) * 2014-12-11 2016-06-16 Phosphorex, Inc. Aqueous topical drug formulation with controlled release and increased stability
US11617724B2 (en) 2015-05-21 2023-04-04 Dermavant Sciences GmbH Topical pharmaceutical compositions
AU2016263161B2 (en) 2015-05-21 2019-02-28 Dermavant Sciences GmbH Topical pharmaceutical compositions
CN106967536B (en) * 2017-03-29 2019-04-02 东北石油大学 Sandstones mother oil displacement tests rock core oil washing agent and preparation method thereof
CN113440483B (en) * 2021-06-30 2023-04-07 佛山市南海东方澳龙制药有限公司 Terbinafine hydrochloride spray for dogs and preparation method thereof
CN116077421B (en) * 2023-01-03 2023-12-12 江苏知原药业股份有限公司 Tacrolimus ointment and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997026917A1 (en) * 1996-01-23 1997-07-31 Chemisch Adviesbureau Drs. J.C.P. Schreuder B.V. Composition for treating skin affections and process for its preparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010013377A (en) * 1997-06-04 2001-02-26 데이비드 엠 모이어 Mild, leave-on antimicrobial compositions
US6761903B2 (en) * 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997026917A1 (en) * 1996-01-23 1997-07-31 Chemisch Adviesbureau Drs. J.C.P. Schreuder B.V. Composition for treating skin affections and process for its preparation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8575189B2 (en) 2008-10-08 2013-11-05 Takata Seiyaku Co., Ltd. Tacrolimus preparation for external applications

Also Published As

Publication number Publication date
EA200601724A1 (en) 2007-02-27
RS20060479A (en) 2008-11-28
BRPI0508933A (en) 2007-08-14
WO2005087195A2 (en) 2005-09-22
EP1734925A2 (en) 2006-12-27
AU2005221427A1 (en) 2005-09-22
ZA200608621B (en) 2008-06-25
EA011244B1 (en) 2009-02-27
CA2559351A1 (en) 2005-09-22
US20080050434A1 (en) 2008-02-28
AP2006003784A0 (en) 2006-10-31
AU2005221427B2 (en) 2008-09-25

Similar Documents

Publication Publication Date Title
WO2005087195A3 (en) Novel compositions for topical delivery
EP2131813B1 (en) Topical pharmaceutical formulation
US11696909B2 (en) Pain-relieving topical compositions
JP2023022177A (en) Therapeutic topical compositions of apremilast
WO2004105694A3 (en) Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
WO2006037116A3 (en) Semi-solid delivery vehicle and pharmaceutical compositions
WO2006082588A3 (en) Method and device for ophthalmic administration of active pharmaceutical ingredients
WO2007022090A3 (en) Topical delivery with a carrier fluid
WO2002096435A3 (en) Skin-permeable composition comprising a selective cyclooxygenase-2 inhibitor a monohydric alcohol
WO2007133751A3 (en) Base-stabilized polyorthoester formulations
WO2005044226A3 (en) Lipid formulations for spontaneous drug encapsulation
CA2494473A1 (en) Stabilized protein compositions for topical administration and methods of making same
WO2005007072A3 (en) Methods and pharmaceutical compositions for healing wounds
CA2747845A1 (en) Compositions and methods for dermally treating pain
WO2001085139A3 (en) Semi-solid delivery vehicle and pharmaceutical compositions
US10993934B2 (en) Topical compositions of dutasteride
KR20010071319A (en) Minoxidil Compositions for External Use
EP0680760A1 (en) Topical antipruritic composition containing a phosphonic acid diester compound
JP6903411B2 (en) Topical composition
JP5832602B2 (en) Pharmaceutical composition for external use
JP2001270826A (en) External medicine for treatment and prevention of dermatopathy
JP2001163783A (en) Agent for external use for treating dermatosis
WO2002041875A3 (en) Method for producing readily soluble medicament formulations and corresponding formulations
AU2022399569A1 (en) Formulation and method for topical treatment of mycobacterium ulcerans in buruli ulcers
WO2023081720A1 (en) Uses of pan bet inhibitors

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: P-2006/0479

Country of ref document: YU

WWE Wipo information: entry into national phase

Ref document number: 12006501748

Country of ref document: PH

WWE Wipo information: entry into national phase

Ref document number: 2559351

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: PA/a/2006/010641

Country of ref document: MX

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Ref document number: DE

WWE Wipo information: entry into national phase

Ref document number: 550312

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: AP/P/2006/003784

Country of ref document: AP

WWE Wipo information: entry into national phase

Ref document number: 2006/08621

Country of ref document: ZA

Ref document number: 2005221427

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 200601724

Country of ref document: EA

WWE Wipo information: entry into national phase

Ref document number: 2005733456

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2005221427

Country of ref document: AU

Date of ref document: 20050317

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2005221427

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2005733456

Country of ref document: EP

ENP Entry into the national phase

Ref document number: PI0508933

Country of ref document: BR

WWE Wipo information: entry into national phase

Ref document number: 10593136

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 10593136

Country of ref document: US